Artelo Biosciences annual debt-to-equity ratio
2020
2021
2021
2022
2023
2024
Artelo Biosciences Debt-to-Equity Ratio Growth & History (ARTL)
Artelo Biosciences's debt-to-equity ratio was 0.04 for fiscal 2024.
View full Artelo Biosciences company overviewArtelo Biosciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.04 | 0.04 | — |
| 2023 | 2023-12-31 | 0.00 | −0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.00 | −43.50% |
| 2021 · Dec 31 | 2021-12-31 | 0.00 | — | — |
| 2021 · Aug 31 | 2021-08-31 | 0.01 | 0.01 | — |
| 2020 | 2020-08-31 | 0.00 | — | — |
Artelo Biosciences quarterly debt-to-equity ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | — | — |
| Q1 2026 | 2026-03-31 | 0.08 | −0.07 | −45.58% |
| Q1 2025 | 2025-03-31 | 0.15 | 0.14 | +1347.49% |
| Q4 2024 | 2024-12-31 | 0.04 | 0.04 | — |
| Q3 2024 | 2024-09-30 | 0.02 | 0.02 | — |
| Q2 2024 | 2024-06-30 | 0.01 | 0.01 | +3131.76% |
| Q1 2024 | 2024-03-31 | 0.01 | 0.01 | +241.43% |
| Q4 2023 | 2023-12-31 | 0.00 | −0.00 | — |
| Q3 2023 | 2023-09-30 | 0.00 | −0.00 | — |
| Q2 2023 | 2023-06-30 | 0.00 | −0.00 | −78.02% |
| Q1 2023 | 2023-03-31 | 0.00 | 0.00 | +55.11% |
| Q4 2022 | 2022-12-31 | 0.00 | −0.00 | −43.50% |
| Q3 2022 | 2022-09-30 | 0.00 | — | — |
| Q2 2022 | 2022-06-30 | 0.00 | — | — |
| Q1 2022 · Mar 31 | 2022-03-31 | 0.00 | — | — |
| Q4 2021 · Dec 31 | 2021-12-31 | 0.00 | — | — |
| Q1 2022 · Nov 30 | 2021-11-30 | 0.00 | 0.00 | — |
| Q4 2021 · Aug 31 | 2021-08-31 | 0.01 | 0.01 | — |
| Q3 2021 | 2021-05-31 | 0.00 | — | — |
| Q2 2021 | 2021-02-28 | 0.00 | — | — |
| Q1 2021 | 2020-11-30 | 0.00 | — | — |
| Q4 2020 | 2020-08-31 | 0.00 | — | — |
Artelo Biosciences debt-to-equity ratio trends
Between the periods ended 2020-08-31 and 2024-12-31, Artelo Biosciences's debt-to-equity ratio increased from 0.00 to 0.04, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artelo Biosciences source filings ↗